UroGen Pharma Ltd. (URGN) Launches uTRACT Registry to Track JELMYTO Use in UTUC
UroGen Pharma Ltd. (NASDAQ: URGN ) has unveiled the design of its pivotal uTRACT Registry study…
biotech & biomedical, investing company news, medicine and healthcare, News, technology
0
ASCO 2025: Harbinger Health reports clinical data of blood-based MCED test
Harbinger Health has reported clinical data at the American Society of Clinical Oncology (ASCO) Annual Meeting…
Ocugen Makes Breakthroughs in Q1 2025: Advancing Gene Therapy Frontiers
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has announced its financial results for the first quarter…